Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
PlainTrials
RecruitingNot a traditional drug phaseinterventionalRules rewrite

Not a traditional drug phase: Neurodynamic stretches for Polycystic Ovarian Syndrome

The study will be a non-blinded randomly assigned controlled trial, consisting of two groups. Non-probability Convenience sampling will be used to recruit participants who will meet the who can join.

Official registry: https://clinicaltrials.gov/study/NCT07645014 · Riphah International University · enrollment listed as 38

What this phase means

This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

If you join, the listed intervention(s) are Neurodynamic stretches, or myofascial pain release technique Interventions:. The registry lists allocation as randomized. The study will be a non-blinded randomly assigned controlled trial, consisting of two groups.

They plan to enroll about 38 people at Lahore. Taking part typically means study visits and measurements plus check-ins.

Official title (unrewritten)

Comparative Effects of Neurodynamic Stretch and Myofascial Pain Release in Dysmenorrhea, Quality Of Sleep And Stress In Polycystic Ovarian Syndrome.

Interventions: Neurodynamic stretches, myofascial pain release technique Interventions:

Primary outcome (registry wording): Mc Gill Questionnaire

Who it is for (from inclusion criteria)

  • Ages 18 Years to 35 Years
  • Women only
  • Diagnosed cases of PCOS
  • Irregular periods until 3 months
  • Presence of dysmenorrhea (Check WaLIDD Questionnaire)
  • Age of Menarche (13 years)

Public study contact (from the registry)

Imran Amjad, PhD

03324390125

imran.amjad@riphah.edu.pk

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

1 listed

FAQ about this NCT record

Is NCT07645014 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT07645014?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT07645014?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary